Medical insurance drug negotiation result announced
A three-day 2021 national medical insurance drug catalog negotiations in Beijing, the final result is expected to announce in November.
The National Medical Insurance Bureau issued the 20021 National Medical Pharmaceutical Directory Adjustment By the preliminary form review, a total of 271 drugs this year passed the initial form of review, of which the new listing of newly listed after 2016.
According to the latest news of the National Medical Insurance Bureau, as China’s first Car-T cell treatment product, Akun injection of Akun, the drug value, the price of more than one million yuan, has just been approved in June this year, although there is an adjustment in the 2021 medical insurance drug catalog By the preliminary formal review of 上海按摩fj体验 the list of drugs, the medical insurance catalog negotiation link is not entered.
The relevant person in charge of the National Medical Insurance Bureau introduced that drugs were more expensive, and only the preliminary form of review was preliminaryly, and the drug was in accordance with the application conditions, the qualification of the next adjustment process was obtained. According to the "2021 National Medical Insurance Drug Directory, the directory adjustment includes the preparation, declaration, review, negotiation, announcement of the results and other stages. Such medicines can ultimately enter the national medical insurance drug catalog, but also accept strict reviews including economics, and exclusive drugs should also be negotiated.
At present, my country’s basic medical insurance 上海kb油压 fundraising levels, especially urban and rural residents, and the current basic medical insurance system in the overall development of medical insurance systems, the treatment of medical insurance funds, and the level of anti-risk capacity of medical insurance funds. It is mainly based on providing basic disease treatment for the masses, focusing on meeting the basic medical needs of the masses.
In the adjusted drug catalog adjustment, the State Medical Insurance Bureau has always firmly grasped the functional positioning of basic medical insurance "basic", focusing on the clinical value, reasonable price, and can meet the drugs that can meet basic medical needs. Since 2000, the national medical insurance drug catalog has been adjusted six times, and the number of drugs in the catalog increased from 1535上海新419网 to 2,800, and the medical security scope is further expanded while optimizing the medical insurance catalog structure.
The National Medical Insurance Bureau said that solving the availability of new drugs can only rely on basic medical insurance, and you can give full play to the channel functions of various supplementary insurance, commercial health insurance, and better through the establishment of a multi-level medical security system that improves Chinese characteristics. Meet different levels of medication requirements.
According to Xinhua News Agency.